Difference between revisions of "RS Belgrade Lalic NM"
From Bioblast
Beno Marija (talk | contribs) |
|||
(11 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
{{O2k-Network Lab | {{O2k-Network Lab | ||
|institution= | |institution=Clinic for Endocrinology, Diabetes and Metabolic DiseasesClinical Center of Serbia | ||
|address=Faculty of Medicine University of BelgradeDr Subotica 13, Belgrade | |||
|area code=11000 | |||
|city=Belgrade | |city=Belgrade | ||
|country=Republic of Serbia | |country=Republic of Serbia | ||
|Contact=Lalic Nebojsa M | |Contact=Lalic Nebojsa M | ||
|MiPNetLab=Krako Nina, Pavlovic Kasja, | |MiPNetLab=Krako Jakovljevic Nina, Pavlovic Kasja, Ivanovic Tijana | ||
|Status=O2k 2016 – | |Status=O2k 2016 – | ||
|info=[[MiPNet15.12 IOC57 Druskininkai LT]] | |info=[[MitoEAGLE_WG4_Matrei_a._Brenner_2019-03| MitoEAGLE 2019 AT]], [[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 LV]], [[MitoEAGLE Obergurgl 2017| MitoEAGLE 2017 AT]], [[MiPschool Obergurgl 2017| MiPschool 2017]], [[MitoEAGLE Verona 2016| MitoEAGLE 2016 IT]], [[IOC112]], [[MiPschool London 2015 | MiPschool 2015]], [[MiP2010]], [[MiPNet15.12 IOC57 Druskininkai LT| IOC57]] | ||
}} | }} | ||
== Bioblast alert == | |||
::::* [[Bioblast alert 2021]] » [[Krako Jakovljevic 2021 MitoFit PD]] |
Latest revision as of 09:50, 13 June 2022
RS Belgrade Lalic NM
O2k-Network Lab | Clinic for Endocrinology, Diabetes and Metabolic DiseasesClinical Center of Serbia |
---|---|
Address | Faculty of Medicine University of BelgradeDr Subotica 13, Belgrade, 11000 |
City | Belgrade |
State/Prov | |
Country | Republic of Serbia |
Weblink | |
Contact | Lalic Nebojsa M |
Team | Krako Jakovljevic Nina, Pavlovic Kasja, Ivanovic Tijana |
Team previous | |
Status | O2k 2016 – |
Oroboros Events | MitoEAGLE 2019 AT, MitoEAGLE 2018 LV, MitoEAGLE 2017 AT, MiPschool 2017, MitoEAGLE 2016 IT, IOC112, MiPschool 2015, MiP2010, IOC57 |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Krako Jakovljevic 2021 Int J Mol Sci | 2021 | Krako Jakovljevic N, Pavlovic K, Jotic A, Lalic K, Stoiljkovic M, Lukic L, Milicic T, Macesic M, Stanarcic Gajovic J, Lalic NM (2021) Targeting mitochondria in diabetes. Int J Mol Sci 22:6642. |
Pesta 2021 Front Endocrinol (Lausanne) | 2021 | Pesta D, Jelenik T, Zaharia OP, Bobrov P, Görgens S, Bódis K, Karusheva Y, Krako Jakovljevic N, Lalic NM, Markgraf DF, Burkart V, Müssig K, Knebel B, Kotzka J, Eckel J, Strassburger K, Szendroedi J, Roden M (2021) NDUFB6 polymorphism is associated with physical activity-mediated metabolic changes in type 2 diabetes. https://doi.org/10.3389/fendo.2021.693683 |
O2k-Abstracts
Published | Reference | |
---|---|---|
Lalic 2109 MiP2019 | 2019 | Pathophysiology of type 2 diabetes and mitochondrial dysfunction: possible therapeutic implications. |
Calabria 2019 MiPschool Coimbra | 2019 | Investigating mitochondrial function in blood cells by high-resolution respirometry: contribution to an interlaboratory study. MitoEAGLE WG4. |
Pavlovic 2019 MiP2019 | 2019 | Effects of therapeutic metformin concentration on mitochondria in muscle cells. |
Zujovic 2019 MiP2019 | 2019 | Cell membrane permeabilization: digitonin optimization pitfalls. |
Krako Jakovljevic 2019 MiP2019 | 2019 | Lower insulin sensitivity differently affects mitochondrial coupling in liver and muscle cells. |
Pavlovic 2017 MITOEAGLE Obergurgl | 2017 | Establishing cellular model for studying mechanisms of muscle insulin resistance: towards understanding the role of mitochondria. |
Krako 2016 Abstract MitoFit Science Camp 2016 | 2016 | Conformational targeting of amyloid β oligomers inside endoplasmic reticulum rescues mitochondrial deficits in 7PA2 cells. |